You are here » Home » Companies » Company Overview » Norris Medicines Ltd

Norris Medicines Ltd.

BSE: 524414 Sector: Others
NSE: N.A. ISIN Code: INE744C01029
BSE 00:00 | 11 Sep 6.75 0
(0.00%)
OPEN

6.75

HIGH

6.75

LOW

6.75

NSE 05:30 | 01 Jan Norris Medicines Ltd
OPEN 6.75
PREVIOUS CLOSE 6.75
VOLUME 90
52-Week high 10.61
52-Week low 3.38
P/E
Mkt Cap.(Rs cr) 7
Buy Price 7.10
Buy Qty 40.00
Sell Price 7.10
Sell Qty 20.00
OPEN 6.75
CLOSE 6.75
VOLUME 90
52-Week high 10.61
52-Week low 3.38
P/E
Mkt Cap.(Rs cr) 7
Buy Price 7.10
Buy Qty 40.00
Sell Price 7.10
Sell Qty 20.00

Norris Medicines Ltd. (NORRISMEDICINES) - Company History

Incorporated on 7 Sep.'90 as a private limited company and promoted by B N Thakore, N J Patel and N L Upadhyaya, Norris Medicines is purely a pharmaceutical formulations-based company. It became a public limited company in Mar.'92. Commercial production of the formulation unit commenced in Nov.'91. The company came out with a public issue aggregating Rs 5 cr in Dec.'93 to expand its existing capacity for tablets, capsules, etc, besides diversifying into bulk drugs and setting up an injectables unit. The project cost of Rs 14.21 cr was financed through loans and equity. The project was delayed by about nine months and was completed in 1995. The company undertakes job work/loan license work of reputed pharmaceuticals majors and expects to continue with the present arrangement besides expecting big boost in exports in the coming years with the PHC groups focus and marketing strengths worldwide.